Measles seroprevalence among healthcare workers in South Korea during the post-elimination period
- PMID: 33689571
- PMCID: PMC8475616
- DOI: 10.1080/21645515.2021.1888623
Measles seroprevalence among healthcare workers in South Korea during the post-elimination period
Abstract
During the measles epidemic in 2019, in-hospital transmission of measles contributed to more than two-thirds of measles cases in South Korea, where measles is declared eliminated. This study aimed to examine measles seropositivity among healthcare workers (HCWs) in South Korea to help develop an effective measles prevention strategy for hospital settings. Measles IgG titer was tested in 1,579 HCWs working in a university-affiliated hospital and the measles-containing vaccine (MCV) immunization records of 870 HCWs were identified. The overall seropositivity was 92.0%, but the seropositivity and antibody titers were significantly low among HCWs aged 20-25 years (78.6%) and among one-dose vaccine recipients (86.7%). Among two-dose recipients, seropositivity was lower among young HCWs who received two doses during their childhood than among those who received the catch-up vaccination as part of job requirements (70.3% vs. 98.0%). Among 87 seronegative HCWs who received two-dose MMR vaccination, the seroconversion rate was 98.9%. A considerable proportion of young HCWs were potentially susceptible to measles despite receiving the two-dose vaccination during childhood because of the waning immunity against measles in a country with measles-eliminated status. Serological screening for measles of newly employed HCWs and MCV immunization of seronegative HCWs appears to be an effective prevention strategy.
Keywords: Measles; South Korea; healthcare worker; seroprevalence; vaccination.
Figures
Similar articles
-
A Lesson from a Measles Outbreak among Healthcare Workers in a Single Hospital in South Korea: The Importance of Knowing the Prevalence of Susceptibility.Vaccines (Basel). 2023 Sep 20;11(9):1505. doi: 10.3390/vaccines11091505. Vaccines (Basel). 2023. PMID: 37766181 Free PMC article.
-
The third dose of measles-containing vaccine induces robust immune responses against measles in young seronegative healthcare workers who had previous two-dose measles vaccination.J Infect Public Health. 2023 Oct;16(10):1643-1649. doi: 10.1016/j.jiph.2023.08.002. Epub 2023 Aug 5. J Infect Public Health. 2023. PMID: 37597451
-
Trend of immunity against measles and varicella zoster virus in healthcare workers in Korea.Vaccine. 2023 Jul 19;41(32):4679-4684. doi: 10.1016/j.vaccine.2023.06.018. Epub 2023 Jun 20. Vaccine. 2023. PMID: 37349224
-
Measles Seroprevalence and Vaccine Responses in Human Immunodeficiency Virus-infected Adolescents and Adults: A Systematic Review.Clin Infect Dis. 2019 Aug 16;69(5):836-844. doi: 10.1093/cid/ciy980. Clin Infect Dis. 2019. PMID: 30452621
-
Prevalence and management of measles susceptibility in healthcare workers in Italy: a systematic review and meta-analysis.Expert Rev Vaccines. 2020 Jul;19(7):611-620. doi: 10.1080/14760584.2020.1791091. Epub 2020 Jul 9. Expert Rev Vaccines. 2020. PMID: 32608272
Cited by
-
Causes of a Low Measles Seroprevalence among Young Healthcare Workers in Korea.Infect Chemother. 2023 Sep;55(3):388-393. doi: 10.3947/ic.2023.0049. Epub 2023 Aug 4. Infect Chemother. 2023. PMID: 37674337 Free PMC article.
-
A Lesson from a Measles Outbreak among Healthcare Workers in a Single Hospital in South Korea: The Importance of Knowing the Prevalence of Susceptibility.Vaccines (Basel). 2023 Sep 20;11(9):1505. doi: 10.3390/vaccines11091505. Vaccines (Basel). 2023. PMID: 37766181 Free PMC article.
-
Immunogenicity and safety of measles-mumps-rubella vaccine delivered by the aerosol, intradermal and intramuscular routes in previously vaccinated young adults: a randomized controlled trial protocol.PLoS One. 2025 Mar 21;20(3):e0318893. doi: 10.1371/journal.pone.0318893. eCollection 2025. PLoS One. 2025. PMID: 40117230 Free PMC article.
-
Rubella Vaccine Uptake among Women of Childbearing Age in Healthcare Settings.Healthcare (Basel). 2023 Nov 19;11(22):2992. doi: 10.3390/healthcare11222992. Healthcare (Basel). 2023. PMID: 37998484 Free PMC article.
-
Seroprevalence for Measles, Varicella, Mumps and Rubella in the Trainee Obstetric Population: A Survey in Southern Italy.Vaccines (Basel). 2024 Mar 20;12(3):335. doi: 10.3390/vaccines12030335. Vaccines (Basel). 2024. PMID: 38543969 Free PMC article.
References
-
- McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS. Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2013;62:1–34. - PubMed
-
- Choi S, Cho EH. Analysis of the occurrence of measles in Korea, 2019. Public Health Wkly Rep. 2020;13:2445–58.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical